Deucravacitinib is an oral selective TYK2 inhibitor that targets the unique pseudokinase domain of the enzyme and inhibits TYK2-mediated pathways with high selectivity over other JAKs (JAK 1/2/3). 9 ...

Cutaneous nontuberculous mycobacterial infection after intra-articular corticosteroid injection in a patient with psoriatic dactylitis ...

UKHSA warns unpleasant infection with grim symptoms is at a 'decade high' in England Cases of this illness rose by 17 per cent in one year sparking concern.

Parakeratosis pustulosa (PP) is a cause of distal nail inflammation and nail dystrophy that affects a single digit. It is nonpruritic and minimally painful. This distal digital dactylitis is ...

Objective To identify clusters of peripheral involvement according to the specific location of peripheral manifestations (ie, arthritis, enthesitis and dactylitis) in patients with spondyloarthritis ...

At baseline, clinical domains like skin, nail and joint affection, dactylitis, enthesitis and axial involvement were similar between the groups. Only the patients’ satisfaction concerning tolerability ...

Campylobacter infection was also associated with international travel, a finding seen in studies of Campylobacter in the general population, [19] but in our population international travel ...

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain treatment with lasting benefits.